TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial
Brief Summary: Panic Disorder with or without agoraphobia (PD/A) is a common, and unless it is treated, often chronic psychiatric disorder. The are effective pharmacological as well as psychological treatments for PD/A. Because of the lack of availability of the most effective psychological treatment, cognitive behavior therapy (CBT), self-help based CBT treatments have been developed. One of those are Internet-based CBT. The aim of this study is to compare the effectiveness of Internet and group CBT for PD/A in a regular psychiatric setting. 113 patients are consecutively and randomly assigned to either treatment (both lasting 10 weeks). The main outcome measure is the Panic Disorder Severity Scale(PDSS). The study hypothesis is that treatments will show equal effectiveness.


Options:
A: Arm Label: Internet-based CBT; Type: N/A; Interventions: N/A
B: Arm Label: Tailored Internet-delivered CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Internet-administrated CBT-Treatment | Arm Label: Waitlist; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Waitlist | Intervention Type: BEHAVIORAL; Name: Tailored Internet-administrated CBT-Treatment; Assigned to Arm(s): Tailored Internet-delivered CBT | Intervention Type: BEHAVIORAL; Name: Waitlist; Assigned to Arm(s): Waitlist
C: Arm Label: Internet CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based cognitive behavior therapy (CBT). | Arm Label: Group CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Group CBT | Intervention Type: BEHAVIORAL; Name: Internet-based cognitive behavior therapy (CBT).; Assigned to Arm(s): Internet CBT | Intervention Type: BEHAVIORAL; Name: Group CBT; Assigned to Arm(s): Group CBT
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-delivered CBT. | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: On line discussion group | Intervention Type: BEHAVIORAL; Name: Internet-delivered CBT.; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: On line discussion group; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, Parallel Group Efficacy Study Comparing the Effect of Inhaled Indacaterol 150 µg o.d. vs Inhaled Tiotropium 18 µg o.d. on Lung Function, Rate of Exacerbations and Related Outcomes in Patients With COPD
Brief Summary: This study compares indacaterol with tiotropium in terms of bronchodilation over 52 weeks


Options:
A: Arm Label: Glyco 25; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: Glyco 50; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: Glyco 100; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrrolate | Arm Label: BDP/FF 400/24; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 25 | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 50 | Intervention Type: DRUG; Name: Glycopyrrolate; Assigned to Arm(s): Glyco 100 | Intervention Type: DRUG; Name: Comparator; Assigned to Arm(s): BDP/FF 400/24
B: Arm Label: arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol / Fluticasone (50/500 µg) BID fixed combination | Arm Label: arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol / Fluticasone (50/500 µg) BID separate Inhalers | Intervention Type: DRUG; Name: Salmeterol / Fluticasone (50/500 µg) BID fixed combination; Assigned to Arm(s): arm 1 | Intervention Type: DRUG; Name: Salmeterol / Fluticasone (50/500 µg) BID separate Inhalers; Assigned to Arm(s): arm 2
C: Arm Label: Indacaterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 µg | Arm Label: Tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium | Intervention Type: DRUG; Name: Indacaterol 150 µg; Assigned to Arm(s): Indacaterol | Intervention Type: DRUG; Name: Tiotropium; Assigned to Arm(s): Tiotropium
D: Arm Label: FF/GW642444 Inhalation Powder 100/25 mcg QD; Type: EXPERIMENTAL; Interventions: Drug: FF/GW642444 Inhalation Powder | Arm Label: FF/GW642444 Inhalation Powder 50mcg/25mcg QD; Type: EXPERIMENTAL; Interventions: Drug: FF/GW642444 Inhalation Powder | Arm Label: FF/GW642444 Inhalation Powder 200/25 mcg QD; Type: EXPERIMENTAL; Interventions: Drug: FF/GW642444 Inhalation Powder | Arm Label: GW642444 25mcg QD; Type: EXPERIMENTAL; Interventions: Drug: GW642444 Inhalation Powder | Intervention Type: DRUG; Name: FF/GW642444 Inhalation Powder; Assigned to Arm(s): FF/GW642444 Inhalation Powder 100/25 mcg QD, FF/GW642444 Inhalation Powder 200/25 mcg QD, FF/GW642444 Inhalation Powder 50mcg/25mcg QD | Intervention Type: DRUG; Name: GW642444 Inhalation Powder; Assigned to Arm(s): GW642444 25mcg QD

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, Parallel Group Efficacy Study Comparing the Effect of Inhaled Indacaterol 150 µg o.d. vs Inhaled Tiotropium 18 µg o.d. on Lung Function, Rate of Exacerbations and Related Outcomes in Patients With COPD
Brief Summary: This study compares indacaterol with tiotropium in terms of bronchodilation over 52 weeks


Options:
A: Arm Label: fluticasone furoate/umeclidinium bromide/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate (FF), Drug: vilanterol (VI), Drug: umeclidinium bromide (UMEC) | Arm Label: fluticasone furoate/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone furoate (FF), Drug: vilanterol (VI) | Arm Label: umeclidinium bromide/vilanterol; Type: EXPERIMENTAL; Interventions: Drug: vilanterol (VI), Drug: umeclidinium bromide (UMEC) | Intervention Type: DRUG; Name: fluticasone furoate (FF); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, fluticasone furoate/vilanterol | Intervention Type: DRUG; Name: vilanterol (VI); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, fluticasone furoate/vilanterol, umeclidinium bromide/vilanterol | Intervention Type: DRUG; Name: umeclidinium bromide (UMEC); Assigned to Arm(s): fluticasone furoate/umeclidinium bromide/vilanterol, umeclidinium bromide/vilanterol
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: AZD9668 | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: AZD9668 | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: AZD9668 | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZD9668 Placebo | Intervention Type: DRUG; Name: AZD9668; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: AZD9668; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: AZD9668; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: AZD9668 Placebo; Assigned to Arm(s): 4
C: Intervention Type: DRUG; Name: Tiotropium bromide 18mcg; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Fluticasone propionate/ salmeterol combination 50/500mcg; Assigned to Arm(s): N/A
D: Arm Label: Indacaterol; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 µg | Arm Label: Tiotropium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium | Intervention Type: DRUG; Name: Indacaterol 150 µg; Assigned to Arm(s): Indacaterol | Intervention Type: DRUG; Name: Tiotropium; Assigned to Arm(s): Tiotropium

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Local Injury to Endometrium on the Day of Oocyte Retrieval in First IVF Cycle on Implantation Rate.
Brief Summary: Local injury on two sights of endometrium are performed in 60 patients in their first IVF cycle and implantation rate are compared with fresh cycles without local injury.


Options:
A: Arm Label: Scrathcing; Type: EXPERIMENTAL; Interventions: Procedure: scratching | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: scratching | Intervention Type: PROCEDURE; Name: scratching; Assigned to Arm(s): Control, Scrathcing
B: Arm Label: Biopsy catheter; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Biopsy catheter | Intervention Type: PROCEDURE; Name: Endometrial Biopsy; Assigned to Arm(s): Biopsy catheter
C: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury
D: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Local Injury to Endometrium on the Day of Oocyte Retrieval in First IVF Cycle on Implantation Rate.
Brief Summary: Local injury on two sights of endometrium are performed in 60 patients in their first IVF cycle and implantation rate are compared with fresh cycles without local injury.


Options:
A: Arm Label: micronized progesterone; Type: EXPERIMENTAL; Interventions: Drug: micronized progesterone | Arm Label: no utrogestan; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: micronized progesterone; Assigned to Arm(s): micronized progesterone
B: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury
C: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group
D: Arm Label: Menotropin/Progesterone vaginal insert; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone vaginal insert, Drug: leuprolide acetate | Arm Label: Menotropin/Progesterone in oil; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone in oil, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone vaginal insert; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone vaginal insert, Drug: Follitropin beta, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone in oil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin beta, Drug: Progesterone in oil, Drug: leuprolide acetate | Intervention Type: DRUG; Name: Menotropin; Assigned to Arm(s): Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone vaginal insert; Assigned to Arm(s): Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Follitropin beta; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone in oil; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Menotropin/Progesterone in oil | Intervention Type: DRUG; Name: leuprolide acetate; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Local Injury to Endometrium on the Day of Oocyte Retrieval in First IVF Cycle on Implantation Rate.
Brief Summary: Local injury on two sights of endometrium are performed in 60 patients in their first IVF cycle and implantation rate are compared with fresh cycles without local injury.


Options:
A: Arm Label: Control - Standard ART treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test - PGS; Type: EXPERIMENTAL; Interventions: Genetic: Next Generation Sequencing after Blastocyst biopsy | Intervention Type: GENETIC; Name: Next Generation Sequencing after Blastocyst biopsy; Assigned to Arm(s): Test - PGS
B: Arm Label: Embryo Transfer with CCS; Type: OTHER; Interventions: Other: Comprehensive Chromosomal Screening | Arm Label: Embryo Transfer without CCS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Comprehensive Chromosomal Screening; Assigned to Arm(s): Embryo Transfer with CCS
C: Arm Label: PGS-FET; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Trophectoderm biopsy, Procedure: Cryopreservation, Procedure: Embryo Transfer | Arm Label: FET; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cryopreservation, Procedure: Embryo Transfer | Arm Label: Fresh; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Embryo Transfer | Intervention Type: PROCEDURE; Name: Trophectoderm biopsy; Assigned to Arm(s): PGS-FET | Intervention Type: PROCEDURE; Name: Cryopreservation; Assigned to Arm(s): FET, PGS-FET | Intervention Type: PROCEDURE; Name: Embryo Transfer; Assigned to Arm(s): FET, Fresh, PGS-FET
D: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Local Injury to Endometrium on the Day of Oocyte Retrieval in First IVF Cycle on Implantation Rate.
Brief Summary: Local injury on two sights of endometrium are performed in 60 patients in their first IVF cycle and implantation rate are compared with fresh cycles without local injury.


Options:
A: Arm Label: Endometrial biopsy arm; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy, Device: Transvaginal ultrasound | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Endometrial biopsy arm | Intervention Type: DEVICE; Name: Transvaginal ultrasound; Assigned to Arm(s): Endometrial biopsy arm
B: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group
C: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury
D: Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Controlled, Parallel-group, 12-week Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Versus Open Label Tiotropium 18 µg Once Daily in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease
Brief Summary: This study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD)


Options:
A: Arm Label: Indacaterol 75 µg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol; Assigned to Arm(s): Indacaterol 75 µg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Placebo
B: Arm Label: Indacaterol 150 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 µg | Arm Label: Indacaterol 300 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 300 μg | Arm Label: Placebo to indacaterol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol 150 µg; Assigned to Arm(s): Indacaterol 150 μg | Intervention Type: DRUG; Name: Indacaterol 300 μg; Assigned to Arm(s): Indacaterol 300 μg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Placebo to indacaterol
C: Arm Label: Indacaterol 150 μg and tiotropium 18 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg | Arm Label: Tiotropium 18 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium 18 μg, Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol 150 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg | Intervention Type: DRUG; Name: Tiotropium 18 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg, Tiotropium 18 μg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Tiotropium 18 μg
D: Arm Label: Indacaterol 150 μg and tiotropium 18 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg | Arm Label: Tiotropium 18 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium 18 μg, Drug: Placebo to indacaterol | Intervention Type: DRUG; Name: Indacaterol 150 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg | Intervention Type: DRUG; Name: Tiotropium 18 μg; Assigned to Arm(s): Indacaterol 150 μg and tiotropium 18 μg, Tiotropium 18 μg | Intervention Type: DRUG; Name: Placebo to indacaterol; Assigned to Arm(s): Tiotropium 18 μg

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open-label, Cross-over Study Comparing Two Vitamin D Supplements for Infants: Liquid Versus D-Strips.
Brief Summary: Vitamin D supplementation (400 IU/d) is recommended for all breastfed infants in Canada. Such recommendation is grounded in the fact that the prevalence of rickets in Canada is higher than desirable, likely due to low maternal-fetal transfer and low intakes postpartum.

There is little data about adherence to supplementation in Canada, but one study shows that in primiparous mothers (n=1937) in Quebec, 58.1 % of those exclusively breast-feeding gave their infant vitamin D supplements in the first six months and 62.1 % of those feeding formula did not. For the Canadian situation, it is not clear if the modality of the supplementation is a barrier to providing the supplement. Thus the overall aim of this study is to test a new delivery system for parental preference and infant acceptance compared to a standard vitamin D supplement.


Options:
A: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
B: Arm Label: Vitamin D + Calcium; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D + Calcium | Arm Label: Calcium; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Calcium | Arm Label: Vitamin D2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D2 | Arm Label: Vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D + Calcium; Assigned to Arm(s): Vitamin D + Calcium | Intervention Type: DIETARY_SUPPLEMENT; Name: Calcium; Assigned to Arm(s): Calcium | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D2; Assigned to Arm(s): Vitamin D2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D, cholecalciferol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D, cholecalciferol | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D, cholecalciferol; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D, cholecalciferol; Assigned to Arm(s): 2
D: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Arm Label: Placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3 (cholecalciferol); Assigned to Arm(s): Vitamin D3

Answer: C